Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Regenicin Inc.
Fiscal year is October-September. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 0 124,653 0 0 0
COGS excluding D&A 0 124,653 0 0 0
Depreciation & Amortization Expense 0 0 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles 0 0 0 0 0
Gross Income 0 (124,653) 0 0 0
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 11,000 75,819 - 2.36M 997,763
Research & Development 0 0 518,902 964,817 80,000
Other SG&A 11,000 75,819 0 1.39M 917,763
Other Operating Expense 0 478,672 3.66M 0 0
Unusual Expense 0 0 0 0 3.14M
EBIT after Unusual Expense 0 0 0 0 (3.14M)
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income - - - - -
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 256,106 6,875 787,719 766,680
Gross Interest Expense 0 256,106 6,875 787,719 766,680
Interest Capitalized 0 0 0 0 0
Pretax Income (11,000) (935,250) (3.67M) (3.15M) (4.9M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 0 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic 0 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income (11,000) (935,250) (3.67M) (3.15M) (4.9M)
Minority Interest Expense 0 0 0 0 0
Net Income (11,000) (935,250) (3.67M) (3.15M) (4.9M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (11,000) (935,250) (3.67M) (3.15M) (4.9M)
Preferred Dividends 0 0 1.37M 108,134 46,198
Net Income Available to Common (11,000) (935,250) (5.04M) (3.25M) (4.95M)
EPS (Basic) 0.00 (0.01) (0.06) (0.04) (0.05)
Basic Shares Outstanding 2.15M 75.41M 84.72M 88.96M 109.14M
EPS (Diluted) 0.00 (0.01) (0.06) (0.04) (0.05)
Diluted Shares Outstanding 2.15M 75.41M 84.72M 88.96M 109.14M
EBITDA (11,000) (679,144) (3.66M) (2.36M) (997,763)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.